Armenia vs Congo: Previously treated cases tested for RR-/MDR-TB
Armenia
100.0%
in 2024
Congo
100.0%
in 2024
Armenia rank
1st
Congo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Armenia
- Congo
How they compare
Armenia currently reports 100.0% against 100.0% in Congo, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2013 it was Armenia ahead.
Armenia ranks 1st and Congo ranks 1st of 180 countries.
Across the 2 decades both report, Armenia averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Armenia | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.0% | 77.2% | 39.2% | Congo |
| 2020s | 98.4% | 69.8% | 28.6% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Armenia or Congo?
- Armenia, at 100.0% against 100.0% in Congo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Armenia and Congo?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Congo?
- 11 years are reported by both, from 2013 to 2024.
- How do Armenia and Congo rank globally for previously treated cases tested for rr-/mdr-tb?
- Armenia ranks 1st and Congo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.